Overview
Kazuaki Hoshi practices practicing medicine in Tokyo, Japan.
Their clinical expertise encompasses Small Cell Lung Cancer (SCLC) and Pulmonary Fibrosis.
They are actively involved in clinical research, co-authoring 16 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kazuaki Hoshi
Is Kazuaki Hoshi a top-rated expert for Small Cell Lung Cancer (SCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Kazuaki Hoshi is classified as an Experienced expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kazuaki Hoshi participate in research or clinical trials?
Yes. Kazuaki Hoshi has published 16 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Kazuaki Hoshi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Pulmonary FibrosisHoshi isExperienced. Learn about Pulmonary Fibrosis.
- Small Cell Lung Cancer (SCLC)Hoshi isExperienced. Learn about Small Cell Lung Cancer (SCLC).